Heterozygous Familial Hypercholesterolemia (HeFH) Management Market: Advancing Precision Lipid-Lowering Therapies
The Heterozygous Familial Hypercholesterolemia HEFH Management Market is set to grow significantly, transitioning from a market size of $8.16 billion in 2024 to an estimated $15.75 billion by 2035. This represents a compound annual growth rate (CAGR) of 6.16%, indicating a strong uptrend in demand for effective treatments and management solutions for this genetic disorder. With a rising...
0 Σχόλια 0 Μοιράστηκε 18 Views 0 Προεπισκόπηση